Background: The aldosterone-to-renin ratio (ARR) is a widely used screening test for
primary aldosteronism. Current guidelines recommend a cut-off value of 91 pmol/mU …

The traditional workup for primary aldosteronism is cumbersome and requires discontinuing
antihypertensive medications, which is inconvenient and potentially dangerous. A simple …

Background. Primary aldosteronism (PA) may account for as much as 6–20% of cases of
refractory hypertension referred to hypertension clinics. Because antihypertensive agents …

Objective To determine whether antihypertensives will affect diagnostic accuracy of the
aldosterone-to-renin ratio (ARR) to an extent that is clinically relevant. Methods Confirmatory …

Since the introduction of the aldosterone-to-renin ratio (ARR) as a screening test for primary
aldosteronism (PA), there has been a marked increase in the reported prevalence of this …

Objective: The accuracy of aldosterone/direct renin concentration ratio (ADRR) as a
screening test in patients with primary aldosteronism (PA) varies widely across the studies …

Objective. We conducted a systematic review of the literature to establish the test
characteristics (sensitivity, specificity, likelihood ratios at different cutoff values) of the …

Background The upright serum aldosterone/upright plasma renin activity ratio (ARR) has
been recommended as a screening tool for the diagnosis of primary aldosteronism …

Objective The aim of this study is to evaluate performance of aldosterone-to-renin ratio
(ARR) before washout of antihypertensive drugs as a screening test for primary …

Background: The ratio of plasma aldosterone concentration to plasma renin activity (PRA) is
considered the screening test of choice for primary aldosteronism. Uncertainty exists …